Patent Assignment
Reel/Frame 044055/0436
Assignment of Assignor's Interest
Recorded: 2017-11-07
Pages: 9
Assignor
PHARMORPHIX, A DIVISION OF SIGMA-ALDRICH COMPANY LTD.
Executed: 2015-03-10
Assignee
EXELIXIS, INC.
210 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties
(3)
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Application:
15/617,725 →
Publication:
US 2018/0002289
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Application:
15/618,593 →
Publication:
US 2018/0037552
Malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer
Application:
15/621,527 →
Publication:
US 2017/0275251
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 7, 2017
From: BROWN, ADRIAN ST. CLAIR
To: PHARMORPHIX, A DIVISION OF SIGMA-ALDRICH COMPANY LTD.
Reel/Frame 044055/0236 →
Assignment of Assignor's Interest
Nov 7, 2017
From: GALLAGHER, WILLIAM P.
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 044055/0595 →
Assignment of Assignor's Interest
Nov 7, 2017
From: BRISTOL-MYERS SQUIBB COMPANY
To: EXELIXIS, INC.
Reel/Frame 044055/0731 →
Assignment of Assignor's Interest
Nov 7, 2017
From: LAMB, PETER
To: EXELIXIS, INC.
Reel/Frame 044055/0909 →